Leu27IGF2 plays an opposite role to IGF1 to induce H9c2 cardiomyoblast cell apoptosis via Gaq signaling

Journal of Molecular Endocrinology

Volumn 43, Issue 6, 2009, Pages 221-230

  Chen, Ray Jade ^a   Wu, His Chin ^a   Chang, Mu Hsin ^b   Lai, Chao Hung ^b   Tien, Yun Chen ^c   Hwang, Jin Ming ^d   Kuo, Wu Hsien ^b   Tsai, Fuu Jen ^c   Tsai, Chang Hai ^e   Chen, Li Mien ^b   Huang, Chih Yang ^c,e   Chu, Chun Hsien ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CASPASE 3; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LEUCINE 27 SOMATOMEDIN B; PHOSPHOLIPASE C BETA; SMALL INTERFERING RNA; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA FRAGMENTATION; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; IMMUNOPRECIPITATION; MYOBLAST; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; RNA SEQUENCE; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE; DNA FRAGMENTATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PROTEIN BINDING; RATS; RECEPTOR, IGF TYPE 2; SIGNAL TRANSDUCTION;

EID: 71649099622     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0121     Document Type: Article

References (31)

1. Balke CW & Shorofsky SR 1998 Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovascular Research 37 290-299. (Pubitemid 28165991)
2. Beukers MW, Oh Y, Zhang H, Ling N & Rosenfeld RG 1991 [Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experiments. Endocrinology 128 1201-1203.
3. Blum JW & Baumrucker CR 2008 Insulin-like growth factors (IGFs), IGF binding proteins, and other endocrine factors in milk: role in the newborn. Advances in Experimental Medicine and Biology 606 397-422.
4. Boker C, von Figura K & Hille-Rehfeld A 1997 The carboxy-terminal peptides of 46 kDa and 300 kDa mannose 6-phosphate receptors share partial sequence homology and contain information for sorting in the early endosomal pathway. Journal of Cell Science 110 1023-1032. (Pubitemid 27216122)
5. Diaz LE, Chuan YC, Lewitt M, Fernandez-Perez L, Carrasco-Rodriguez S, Sanchez-Gomez M & Flores-Morales A 2007 IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor. Molecular Human Reproduction 13 567-576. (Pubitemid 47243549)
6. Fujio Y, Nguyen T, Wencker D, Kitsis RN & Walsh K 2000 Akt promotes survival of cardiomyocytes in vitro and protects against ischemiareperfusion injury in mouse heart. Circulation 101 660-667. (Pubitemid 30094738)
7. Grazette LP & Rosenzweig A 2005 Role of apoptosis in heart failure. Heart Failure Clinics 1 251-261.
8. Hawkes C, Jhamandas JH, Harris KH, Fu W, MacDonald RG & Kar S 2006 Single transmembrane domain insulin-like growth factor-II/mannose-6-phosphate receptor regulates central cholinergic function by activating a G-protein-sensitive, protein kinase C-dependent pathway. Journal of Neuroscience 26 585-596. (Pubitemid 43237124)
9. Huang CY, Hao LY & Buetow DE 2002 Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF1R is IGF-II-dependent. Molecular and Cellular Biochemistry 233 65-72.
10. Ikezu T, Okamoto T, Giambarella U, Yokota T & Nishimoto I 1995 In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G proteins. Distinct roles of cytoplasmic domains and signal sequestration by the receptor. Journal of Biological Chemistry 270 29224-29228.
11. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
12. Kang PM & Izumo S 2000 Apoptosis and heart failure: a critical review of the literature. Circulation Research 86 1107-1113. (Pubitemid 30396034)
13. Kar S, Seto D, Dore S, Hanisch U & Quirion R 1997 Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. PNAS 94 14054-14059. (Pubitemid 28009708)
14. Kluge A, Zimmermann R, Munkel B, Verdouw PD, Schaper J & Schaper W 1995 Insulin-like growth factor II is an experimental stress inducible gene in a porcine model of brief coronary occlusions. Cardiovascular Research 29 708-716.
15. Korner C, Nurnberg B, Uhde M & Braulke T 1995 Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains. Journal of Biological Chemistry 270 287-295.
16. Kuo WW, Liu CJ, Chen LM, Wu CH, Chu CH, Liu JY, Lu MC, Lin JA, Lee SD & Huang CY 2006 Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II. Apoptosis 11 1075-1089.
17. Lee SD, Chu CH, Huang EJ, Lu MC, Liu JY, Liu CJ, Hsu HH, Lin JA, Kuo WW & Huang CY 2006 Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. American Journal of Physiology. Endocrinology and Metabolism 291 E306-E314.
18. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P & Lala PK 2001 Stimulation of human extra-villous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. Journal of Clinical Endocrinology and Metabolism 86 3665-3674. (Pubitemid 32755959)
19. McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J et al. 2004 The insulinlike growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. Journal of Biological Chemistry 279 4782-4793. (Pubitemid 38199073)
20. Okamoto T & Nishimoto I 1991 Analysis of stimulation-G protein subunit coupling by using active insulin-like growth factor II receptor peptide. PNAS 88 8020-8023. (Pubitemid 21915287)
21. Parrizas M, Gazit A, Levitzki A, Wertheimer E & LeRoith D 1997a Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138 1427-1433. (Pubitemid 27137089)
22. Parrizas M, Saltiel AR & LeRoith D 1997b Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 30-kinase and mitogen-activated protein kinase pathways. Journal of Biological Chemistry 272 154-161. (Pubitemid 27021138)
23. Ren J, Samson WK & Sowers JR 1999 Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. Journal of Molecular and Cellular Cardiology 31 2049-2061. (Pubitemid 29537604)
24. Riedl SJ & Shi Y 2004 Molecular mechanisms of caspase regulation during apoptosis. Nature Reviews. Molecular Cell Biology 5 897-907. (Pubitemid 39486541)
25. Rockman HA, Koch WJ & Lefkowitz RJ 2002 Seven-transmembranespanning receptors and heart function. Nature 415 206-212.
26. Sferruzzi-Perri AN, Owens JA, Pringle KG, Robinson JS & Roberts CT 2006 Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth. Endocrinology 147 3344-3355.
27. Singer WD, Brown HA & Sternweis PC 1997 Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D. Annual Review of Biochemistry 66 475-509.
28. Smrcka AV, Hepler JR, Brown KO & Sternweis PC 1991 Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 251 804-807.
29. Song LN, Coghlan M & Gelmann EP 2004 Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Molecular Endocrinology 18 70-85. (Pubitemid 38073155)
30. Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF & Reed JC 1999 Ca2C-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284 339-343. (Pubitemid 129523456)
31. Yue C & Sanborn BM 2001 KN-93 inhibition of G protein signaling is independent of the ability of Ca2C/calmodulin-dependent protein kinase II to phosphorylate phospholipase Cbeta3 on 537-Ser. Molecular and Cellular Endocrinology 175 149-156. (Pubitemid 32372551)